Bispectral Index Throughout Esophageal Cancer Operation
Which Bispectral Index Score is Reliable Throughout Esophageal Cancer Operation?
1 other identifier
interventional
44
1 country
1
Brief Summary
The investigators try to conduct a study to assess the impact of changing patients' lateral decubitus position on BIS readings during esophageal cancer operation. Also, the investigators evaluate the effects of one-lung ventilation and total lung ventilation on BIS value with inhalation agent.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2018
CompletedFirst Posted
Study publicly available on registry
January 12, 2018
CompletedStudy Start
First participant enrolled
January 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 3, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 3, 2018
CompletedSeptember 4, 2018
January 1, 2018
7 months
January 2, 2018
August 30, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Bispectral index score
The difference of both side BIS value on lateral decubitus position
after lateral decubitus position 5 mins, 10 mins, 20 mins, 30 mins
Secondary Outcomes (3)
the asymmetry of BIS
after supine position 5 mins, 10 mins, 20 mins, 30 mins
oxygenation and BIS
intraoperative
The changes of BIS
intraoperative
Study Arms (1)
BIS group
OTHERPatients who received the esophageal surgery
Interventions
Eligibility Criteria
You may qualify if:
- the patients who are planned the esophageal cancer operation
You may not qualify if:
- patient who has dermatitis
- patient who refuse to participate in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsung medical center
Seoul, 06351, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2018
First Posted
January 12, 2018
Study Start
January 15, 2018
Primary Completion
August 3, 2018
Study Completion
August 3, 2018
Last Updated
September 4, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share